These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32873604)

  • 1. Facilitators, barriers and lessons learnt from the first state-wide naloxone distribution conducted in West Virginia.
    Rudisill TM; Ashraf AJ; Linn HI; Sayres S; Jeffries JE; Gurka KK
    Inj Prev; 2021 Aug; 27(4):369-374. PubMed ID: 32873604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study.
    Young S; Williams S; Otterstatter M; Lee J; Buxton J
    BMJ Open; 2019 Oct; 9(10):e030046. PubMed ID: 31662368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.
    Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB
    Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.
    Drainoni ML; Koppelman EA; Feldman JA; Walley AY; Mitchell PM; Ellison J; Bernstein E
    BMC Res Notes; 2016 Oct; 9(1):465. PubMed ID: 27756427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.
    Binswanger IA; Koester S; Mueller SR; Gardner EM; Goddard K; Glanz JM
    J Gen Intern Med; 2015 Dec; 30(12):1837-44. PubMed ID: 26055224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hostility, compassion and role reversal in West Virginia's long opioid overdose emergency.
    Ondocsin J; Mars SG; Howe M; Ciccarone D
    Harm Reduct J; 2020 Oct; 17(1):74. PubMed ID: 33046092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to implementation of opioid overdose prevention programs in Ohio.
    Winstanley EL; Clark A; Feinberg J; Wilder CM
    Subst Abus; 2016; 37(1):42-6. PubMed ID: 26682929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members.
    Wagner KD; Bovet LJ; Haynes B; Joshua A; Davidson PJ
    Drug Alcohol Depend; 2016 Aug; 165():22-8. PubMed ID: 27262898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdose Experiences among People Who Inject Drugs in West Virginia: Personal Loss, Psychological Distress, Naloxone, and Fentanyl.
    Schneider KE; Allen ST; Winiker AK; White RH; O'Rourke A; Sherman SG; Grieb SM
    Subst Use Misuse; 2023; 58(1):22-26. PubMed ID: 36371695
    [No Abstract]   [Full Text] [Related]  

  • 12. Local health departments and the implementation of evidence-based policies to address opioid overdose mortality.
    Feuerstein-Simon R; Lowenstein M; Sharma M; Dupuis R; Luna Marti X; Cannuscio CC
    Subst Abus; 2020; 41(4):468-474. PubMed ID: 32213045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of enforcing cell phone use while driving laws among police: a qualitative study.
    Rudisill TM; Baus AD; Jarrett T
    Inj Prev; 2019 Dec; 25(6):494-500. PubMed ID: 30291154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.
    Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST
    Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction stigma and the production of impediments to take-home naloxone uptake.
    Fomiatti R; Farrugia A; Fraser S; Dwyer R; Neale J; Strang J
    Health (London); 2022 Mar; 26(2):139-161. PubMed ID: 32529843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national survey of law enforcement post-overdose response efforts.
    Ray B; Richardson NJ; Attaway PR; Smiley-McDonald HM; Davidson P; Kral AH
    Am J Drug Alcohol Abuse; 2023 Mar; 49(2):199-205. PubMed ID: 36820614
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioid Overdose Outbreak - West Virginia, August 2016.
    Massey J; Kilkenny M; Batdorf S; Sanders SK; Ellison D; Halpin J; Gladden RM; Bixler D; Haddy L; Gupta R
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):975-980. PubMed ID: 28934186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.
    Chronister KJ; Lintzeris N; Jackson A; Ivan M; Dietze PM; Lenton S; Kearley J; van Beek I
    Drug Alcohol Rev; 2018 May; 37(4):464-471. PubMed ID: 27071354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia.
    Deonarine A; Amlani A; Ambrose G; Buxton JA
    Harm Reduct J; 2016 May; 13(1):17. PubMed ID: 27206486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
    Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.